维斯塔:癌症免疫治疗的新检查点
Yu Gao1, Yanting He2, Yuanyuan Tang1
1Translational Medical Center, Weifang Second People's Hospital, Weifang 261041, Shandong, China.
Drug discovery today
|May 26, 2024
概括
维域Ig抑制T细胞激活 (VISTA) 影响瘤免疫力和T细胞调节. 了解VISTA的使用方法
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 维域Ig抑制T细胞激活 (VISTA) 是B7家族的免疫调节蛋白.
- 维斯塔在维持T细胞静止和调节抗瘤免疫反应方面发挥着关键作用.
- 新兴的临床数据表明VISTA在瘤免疫力中的复杂作用.
研究的目的:
- 审查有关VISTA在各种恶性瘤中的表达的当前文献.
- 阐明VISTA在瘤微环境中的复杂作用.
- 探索VISTA在癌症免疫治疗中的功能.
主要方法:
- 关于VISTA的科学出版物的文献综述.
- 在不同类型的癌症中分析VISTA表达模式.
- 关于VISTA对瘤免疫力和免疫治疗的影响的综合数据.
主要成果:
- 在不同的恶性瘤中,VISTA的表达有所不同.
- 在瘤微环境中,VISTA表现出复杂的调节功能.
- 有证据表明VISTA会影响癌症免疫治疗的疗效.
结论:
- 维斯塔在瘤免疫中的多方面的作用需要进一步研究.
- 了解VISTA的表达和功能为癌症提供了潜在的治疗策略.
- 向VISTA可能代表癌症免疫疗法的新方法.
相关概念视频
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Cancer Vaccines
355
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
355
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


